Interestingly, DRD2 is overexpressed in GB and in midline brain tumors: a DRD2 blockade is sufficient to inactivate growth factor signaling and induce apoptosis; thus, these tumors have enhanced sensitivity to DRD2 antagonists [43]. This evidence concerns the gene DRD2 and brain neoplasm.